Skip to main
NTLA
NTLA logo

Intellia Therapeutics (NTLA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Intellia Therapeutics (NTLA) Stock

About Intellia Therapeutics (NTLA)

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncologica...read more
Market cap$971.61M
Today's volume4.18M
Revenue (TTM)$45.57M
Avg. daily volume4.49M
EBITDA (TTM)-$524.3M
Open$9.23
Price / earnings ratio-1.79x
Today's range$8.98 - $10.13
Debt / equity15.29x
52 week range$5.9 - $28.18
5 year debt / equity10.57x
Beta (LTM)1.57x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio4.9x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Intellia Therapeutics Stock Rating

What analysts recommend for NTLA stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for NTLA stock is $971.61M

The current P/E ratio for NTLA stock is -1.79

The 52-week high for NTLA stock is $28.18. The current NTLA stock price $undefined is 100.00% below its 52-week high

The 52-week low for NTLA stock is $5.90. The current NTLA stock price $undefined has increased 100.00% from its 52-week low

No, the NTLA stock does not pay dividends to its shareholders

The target price for NTLA stock is $53.15 based on the average of what a group of analyst think NTLA stock could be worth at a future date. This is not a prediction by Public.com

How to buy NTLA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NTLA stock

    Navigate to the Explore page. Then, type NTLA into the search bar. When you see NTLA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NTLA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Intellia Therapeutics Stock Earnings

The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained.

Intellia Therapeutics (NTLA) reported Q1 2025 earnings per share (EPS) of -$1.10, beating estimates of -$1.27 by 13.39%. In the same quarter last year, Intellia Therapeutics's earnings per share (EPS) was -$1.12. Intellia Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$1.01.

Buy Intellia Therapeutics (NTLA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.